Cancer research is a global endeavour. The breakthroughs that will help us prevent, diagnose and treat cancer depend on bringing together the brightest minds, diverse perspectives and expertise from ...

Scientists have discovered a key protein that could be targeted with a drug to treat the most common and aggressive form of pancreatic cancer. The findings, published in Nature, show that blocking the ...

Image: Neuroblastoma of the adrenal gland. Credit: Ed Uthman. CC BY-NC 2.0 Neuroblastoma is the most common childhood cancer, and each year, around 100 families will receive the terrible news that ...

Image: A scanning electron microscope image of a prostate cancer cell. Credit: Anne Weston, Francis Crick Institute. CC BY-NC 4.0. At The Institute of Cancer Research, London, we often refer to ...

Regular leisure time physical activity may reduce the risk of breast cancer for women before menopause, according to new research funded by Breast Cancer Now. The research, published today (Monday 11 ...

A promising new therapy can help patients with aggressive advanced breast cancer live longer and delay the need for further chemotherapy, new research has shown. The international study, funded by ...

As we enter 2026, scientists at The Institute of Cancer Research, London, share the developments expected this year that could soon change how cancer is treated – from technologies designed to deliver ...

Today, the first men have been invited to join the ambitious £42 million TRANSFORM screening trial, kicking off the biggest prostate cancer screening study in a generation. The trial will test the ...

The Institute of Cancer Research, London, works closely with trusts, foundations and charity partners who play an important part in enabling our state-of-the-art research. We recently marked a ...

Up to two in five advanced prostate cancer patients could be treated with a combination of two targeted drugs, according to new research. Findings by a team of scientists at The Institute of Cancer ...

Over the last four decades, radiotherapy has seen a technological revolution – evolving from broad, relatively simple deliveries to highly targeted, patient-specific treatment. Few individuals have ...

A targeted cancer treatment given via a simple injection under the skin shrank tumours in more than one third of patients with recurrent and/or metastatic head and neck cancer whose disease has ...